Clinical Trial Update: Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome

View source ↗

Summary

This clinical trial update reports on the kinetics of copeptin in critically ill patients with Posterior Reversible Encephalopathy Syndrome (PRES).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posterior Reversible Encephalopathy Syndrome

Snippet

Sponsor: University Hospital, Tours | Conditions: Posterior Reversible Encephalopathy Syndrome | Status: COMPLETED